Implementing the National Institute of Clinical Excellence improving outcome guidelines for head and neck cancer: developing a business plan with reorganisation of head and neck cancer services

Abstract
• The implementation of the National Institute of Clinical Excellence improving outcome guidelines (NICE‐IOG) manual for head and neck cancer may have a huge potential cost implication. • Head and neck cancer is a rare disease which utilises large quantities of resources which can only be provided in a tertiary centre. • Head and neck cancer services should be centralised into a single site for each cancer network. • A new higher tariff rate for complex head and neck cancer cases is needed which recognises the true cost of this work. • Each network should set its own tariff to make head and neck cancer care financially viable.

This publication has 1 reference indexed in Scilit: